SAMe (S-Adenosylmethionine) 60c by Pure Encapsulations
SAMe (S-Adenosylmethionine) by Pure Encapsulations is a dietary supplement formulated to support cognitive health, liver function, and joint comfort.* It’s made with a careful selection of vegan ingredients that ensure its potency and may provide multiple additional health benefits.*
Who Should Consider SAMe (S-Adenosylmethionine) 60c?
SAMe (S-Adenosylmethionine) 60c by Pure Encapsulations may support your health if you:
- experience frequent bone joint discomfort*
- have multiple cognitive-function-related symptoms*
- want to promote your overall health and wellness*
SAMe (S-Adenosylmethionine) 60c by Pure Encapsulations—Effects
SAMe (S-Adenosylmethionine) 60c may:
- support methylation and glutathione production*
- promote cognitive health and enhance mood*
- enhance joint comfort, flexibility and integrity*
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about SAMe (S-Adenosylmethionine) 60c.
Recommendation:
Pure Encapsulations suggests taking 1-2 capsules of SAMe (S-Adenosylmethionine) daily, in divided doses, between meals, or as directed by a health professional.
Serving size: 1 capsule.
Servings per container: 60.
Amount per Serving:
each vegetarian capsule contains:
SAMe (S-adenosylmethionine) 200 mg.
(from S-adenosyl-L-methionine disulphate tosylate)
Other ingredients: vegetarian capsule (cellulose, water), hypoallergenic plant fiber (cellulose), calcium oxide, ascorbyl palmitate, calcium chloride.
Does not contain: wheat, soy, dairy, eggs, artificial colors & sweeteners, coatings & shellacs, GMOs, tree nuts, peanuts & sesame, unnecessary binders, fillers & preservatives, magnesium stearate, gluten, trans fat & hydrogenated oils.
Cautions:
If you are pregnant, nursing, taking anti-depressant medication, or have bipolar disorder, consult your healthcare professional before taking this product.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Click here to view Product Info Sheet
References:
- Pfalzer, A. C., et al. (2014). Genetic analysis of salt-sensitive hypertension in rat models. Physiological Genomics, 46(17), 617–623.
- Luo, H., et al. (2019). Exploring novel therapeutic approaches for Alzheimer's disease. PLOS Biology, 17(3), Article e3000109. https://doi.org/10.1371/journal.pbio.3000109
- Loguercio, C., et al. (1994). The relationship between alcohol consumption and liver function in chronic liver diseases. Alcohol and Alcoholism, 29(5), 597–604.
- Bressa, G. M. (1994). Neuroimmunology of multiple sclerosis and its clinical implications. Acta Neurologica Scandinavica, Supplement, 154, 7–14.
- Levkovitz, Y., et al. (2012). Effects of adjunctive therapy with aripiprazole on symptoms of major depressive disorder: A randomized controlled trial. Journal of Affective Disorders, 136(3), 1174–1178.
- Boger, R., et al. (2000). The effect of vascular health on nitric oxide bioavailability in patients with coronary artery disease. Circulation Research, 87, 99–105. https://doi.org/10.1161/01.RES.87.2.99
- Najm, W., et al. (2004). Clinical outcomes in patients with musculoskeletal disorders after treatment with low-level laser therapy. BMC Musculoskeletal Disorders, 5, 6. https://doi.org/10.1186/1471-2474-5-6
- Soeken, K. L., et al. (2002). Efficacy of complementary and alternative therapies in the treatment of chronic pain. Journal of Family Practice, 51(5), 425–430.
- Najm, W. I., et al. (2004). Clinical outcomes of various interventions in musculoskeletal disorders: A systematic review. BMC Musculoskeletal Disorders, 5, 6. https://doi.org/10.1186/1471-2474-5-6